Navigation Links
Nephros Engages Joseph S. Cervia, M.D. as Strategic Consultant
Date:11/21/2011

;are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. Actual results may differ materially from the expectations contained in the forward-looking statements. Factors that may cause such differences include the risks that:

 

  • we may not be able to continue as a going concern;
  • we may not be able to obtain funding if and when needed or on terms favorable to us in order to continue operations;
  • we may not obtain appropriate or necessary regulatory approvals to achieve our business plan or effectively market our products including, without limitation, FDA approval of our HDF system;
  • products that appeared promising to us in research or clinical trials may not demonstrate anticipated efficacy, safety or cost savings in subsequent pre-clinical or clinical trials;
  • we may encounter problems with our suppliers and manufacturers;
  • we may encounter unanticipated internal control deficiencies or weaknesses or ineffective disclosure controls and procedures;
  • HDF therapy may not be accepted in the United States and/or our technology and products may not be accepted in current or future target markets, which could lead to failure to achieve market penetration of our products;
  • we may not be able to sell our ESRD therapy or water filtration products at competitive prices or profitably;
  • we may not be able to secure or enforce adequate legal protection, including patent protection, for our products; and
  • we may not be able to achieve sales growth in Europe and Canada or expand into other key geographic markets.

More detailed information about us and the risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in our filings with the SEC, including our Annual Repo
'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nephros Reports Third Quarter 2011 Financial Results
2. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
3. Nephros Reports Second Quarter 2011 Financial Results
4. Nephros Files 510(k) Application for Hemodiafiltration System
5. Nephros Receives 510k Approval to Market Additional Ultrafiltration Products
6. Nephros Reports First Quarter 2011 Financial Results
7. Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada
8. Nephros Reports 2010 Fourth Quarter and Full Year Financial Results
9. Nephros Announces Split Adjusted Trade Date
10. Nephros Announces Completion of Reverse Stock Split
11. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
(Date:12/17/2014)... STUTTGART , Alemania, December 17, 2014 ... del año anterior, con un alto nivel de gasto ... pasado año fiscal 2013/14 (finalizado el 30 de septiembre ... por ciento a 4.287 millones de euros (año anterior: ... de la moneda desfavorables. Las ganancias (EBIT) crecieron un ...
(Date:12/17/2014)... , Dec. 17, 2014  Northstar Global ... Depository Trust Company (DTC) has made their final ... Chill on the Company,s stock effective December 15, ... common stock for depository and book entry transfer ... Company is now once again fully "DTC Eligible", ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS confirma su posición en un entorno difícil 2Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3
... 8, 2011 INNOPHARMA LLC announced ... for levetiracetam injection (the generic equivalent of Keppra® injection from ... injectable drug, INNOPHARMA entered into a license agreement with X-GEN ... About INNOPHARMA: INNOPHARMA ...
... 8, 2011 Echo Therapeutics, Inc. (Nasdaq: ... as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) ... delivery, today announced the receipt of notices of issuance ... notices of registration for the trademarks PRELUDE and SYMPHONY. ...
Cached Medicine Technology:Echo Therapeutics Announces Multiple Patents and Trademark Grants 2Echo Therapeutics Announces Multiple Patents and Trademark Grants 3
(Date:12/19/2014)... December 20, 2014 It’s very easy to ... something that is put to the wayside until Christmas and ... have that travel “itch” and that burning desire to just ... families on their journey to Telluride with a no-fuss, affordable ... to and from the resort, and ensure that all accommodations ...
(Date:12/19/2014)... Silver Dollar City is picking up ... the first time ever, Silver Dollar City has a title ... 2015, listing the park’s wood coaster Outlaw Run as the ... announced this week, Silver Dollar City is named in CNN ... USA Today’s 10Best awards for “Best Public Lights Display,” and ...
(Date:12/19/2014)... 2014 The Medspa at Hendrick in ... from respected cosmetic brand Juvéderm. Voluma XC treats volume ... The Medspa at Hendrick is pleased to be able ... technology to its clients. , Voluma is the first ... to treat the mid-face and cheek area. This non-invasive ...
(Date:12/19/2014)... -- Potentially illness-causing E. coli bacteria were found on ... to a new study. Researchers checked cilantro, basil ... markets in Los Angeles and Orange counties in California, ... samples tested, 24 percent were positive for E. coli. ... researchers. Both types of bacteria can cause sometimes ...
(Date:12/19/2014)... December 19, 2014 Surviving Mesothelioma says thousands ... information indicates that these pipes can leach asbestos into drinking ... the full story on the Surviving Mesothelioma website. ... of natural asbestos deposits, decaying water mains made of asbestos ... , To protect consumers from mesothelioma , water ...
Breaking Medicine News(10 mins):Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2
... Childhood has shown that chidren who are overweight// at age ... starts from childhood and there are evidences to show that ... adulthood. But studies on the associations of body size with ... present study was undertaken to determine the association between obesity ...
... people may cause similar kind of brain damage as happens// ... in the age group of 17 to 26yrs may be ... non-addicted counterparts, said a study done by scientists of University ... equivalent to that happens in the early stage of Alzheimer’s ...
... et al., "Expression profiles and functional analyses of Wnt-related genes// ... of The American Journal of Pathology. The article revolves around ... disruption can lead to cancer in various organs. But current ... joint disease. ,At present a through analysis of the ...
... JAMA says that infective endocarditis is largely due to staphylococcal ... is an infection that affects the inner linings of the ... valves, the connective tissues surrounding the valves, and the inner ... also affect the linings of the arteries coming out of ...
... found that older women suffering from chronic cytomegalovirus// (CMV)(a lifelong ... more than triple the risk of being frail than those ... the Journal of the American Geriatrics Society. This is the ... been shown. CMV is a common lifelong infection but it ...
... Based on findings of a recent study researchers say that ... in milk, cheese, yogurt and fortified orange juice can actually ... (PMS) symptoms. ,Studies in the past have shown that ... studies suggest that when calcium is combined with enough vitamin ...
Cached Medicine News:Health News:Arthritis and the Wnt Factor 2
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
... KWIK-QC Slides have a positive and ... sample inoculation. With these slides, perform QC ... ,Laboratories enhance their education and training programs ... and interpretation, all on one slide! KWIK-QC ...
Each slide contains Giardia lamblia trophozoites applied as a mono-layer to the side....
Each slide contains a high yield of concentrated C. parvum oocysts within the positive control well. A negative control well is also included....
Medicine Products: